These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32689979)

  • 1. Non-active implantable device treating acid reflux with a new dynamic treatment approach: 1-year results : RefluxStop™ device; a new method in acid reflux surgery obtaining CE mark.
    Bjelović M; Harsányi L; Altorjay Á; Kincses Z; Forsell P;
    BMC Surg; 2020 Jul; 20(1):159. PubMed ID: 32689979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating acid reflux without compressing the food passageway: 4-year safety and clinical outcomes with the RefluxStop device in a prospective multicenter study.
    Harsányi L; Kincses Z; Zehetner J; Altorjay Á
    Surg Endosc; 2024 Oct; 38(10):6060-6069. PubMed ID: 39138680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcomes of Patients Receiving a Magnetic Sphincter Augmentation Device for Gastroesophageal Reflux.
    Ganz RA; Edmundowicz SA; Taiganides PA; Lipham JC; Smith CD; DeVault KR; Horgan S; Jacobsen G; Luketich JD; Smith CC; Schlack-Haerer SC; Kothari SN; Dunst CM; Watson TJ; Peters J; Oelschlager BK; Perry KA; Melvin S; Bemelman WA; Smout AJ; Dunn D
    Clin Gastroenterol Hepatol; 2016 May; 14(5):671-7. PubMed ID: 26044316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial.
    Bonavina L; DeMeester T; Fockens P; Dunn D; Saino G; Bona D; Lipham J; Bemelman W; Ganz RA
    Ann Surg; 2010 Nov; 252(5):857-62. PubMed ID: 21037442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center.
    Bonavina L; Saino G; Bona D; Sironi A; Lazzari V
    J Am Coll Surg; 2013 Oct; 217(4):577-85. PubMed ID: 23856355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year results of intermittent electrical stimulation of the lower esophageal sphincter treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oxenberg D; Perez-Castilla A; Netto MG; Soffer E; Boscardin WJ; Crowell MD
    Surgery; 2015 Mar; 157(3):556-67. PubMed ID: 25726315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the feasibility and safety of laparoscopic anti-reflux surgery with the new RefluxStop™ device: a retrospective cohort study of 40 patients.
    Fringeli Y; Linas I; Kessler U; Zehetner J
    Swiss Med Wkly; 2024 Jul; 154():3365. PubMed ID: 39137342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic Sphincter Augmentation for Gastroesophageal Reflux at 5 Years: Final Results of a Pilot Study Show Long-Term Acid Reduction and Symptom Improvement.
    Saino G; Bonavina L; Lipham JC; Dunn D; Ganz RA
    J Laparoendosc Adv Surg Tech A; 2015 Oct; 25(10):787-92. PubMed ID: 26437027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of Magnetic Sphincter Augmentation for Gastroesophageal Reflux Disease.
    Schwameis K; Nikolic M; Morales Castellano DG; Steindl A; Macheck S; Kristo I; Zörner B; Schoppmann SF
    World J Surg; 2018 Oct; 42(10):3263-3269. PubMed ID: 29619511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial.
    Bell R; Lipham J; Louie B; Williams V; Luketich J; Hill M; Richards W; Dunst C; Lister D; McDowell-Jacobs L; Reardon P; Woods K; Gould J; Buckley FP; Kothari S; Khaitan L; Smith CD; Park A; Smith C; Jacobsen G; Abbas G; Katz P
    Gastrointest Endosc; 2019 Jan; 89(1):14-22.e1. PubMed ID: 30031018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease.
    Rodríguez L; Rodriguez P; Gómez B; Ayala JC; Oksenberg D; Perez-Castilla A; Netto MG; Soffer E; Crowell MD
    Endoscopy; 2013 Aug; 45(8):595-604. PubMed ID: 23881803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
    Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
    Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation.
    Rogers BD; Valdovinos LR; Crowell MD; Bell R; Vela MF; Gyawali CP
    Gut; 2021 Mar; 70(3):450-455. PubMed ID: 32467089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteryx implantation for GERD: expanded multicenter trial results and interim postapproval follow-up to 24 months.
    Cohen LB; Johnson DA; Ganz RA; Aisenberg J; Devière J; Foley TR; Haber GB; Peters JH; Lehman GA
    Gastrointest Endosc; 2005 May; 61(6):650-8. PubMed ID: 15855967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary results of Chinese magnetic sphincter augmentation in treating gastroesophageal reflux disease].
    Sun YF; Jiang HY; Gu HY; He Y; Yang Y; Zhang XB; Yang Y; Hua R; Guo XF; Ye B; Mao T; Li ZG
    Zhonghua Wai Ke Za Zhi; 2020 Sep; 58(9):691-696. PubMed ID: 32878416
    [No Abstract]   [Full Text] [Related]  

  • 16. Electrical stimulation therapy of the lower oesophageal sphincter for refractory gastro-oesophageal reflux disease - interim results of an international multicentre trial.
    Kappelle WF; Bredenoord AJ; Conchillo JM; Ruurda JP; Bouvy ND; van Berge Henegouwen MI; Chiu PW; Booth M; Hani A; Reddy DN; Bogte A; Smout AJ; Wu JC; Escalona A; Valdovinos MA; Torres-Villalobos G; Siersema PD
    Aliment Pharmacol Ther; 2015 Sep; 42(5):614-25. PubMed ID: 26153531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six to 12-year outcomes of magnetic sphincter augmentation for gastroesophageal reflux disease.
    Ferrari D; Asti E; Lazzari V; Siboni S; Bernardi D; Bonavina L
    Sci Rep; 2020 Aug; 10(1):13753. PubMed ID: 32792508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial.
    Zacherl J; Roy-Shapira A; Bonavina L; Bapaye A; Kiesslich R; Schoppmann SF; Kessler WR; Selzer DJ; Broderick RC; Lehman GA; Horgan S
    Surg Endosc; 2015 Jan; 29(1):220-9. PubMed ID: 25135443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal sphincter device for gastroesophageal reflux disease.
    Ganz RA; Peters JH; Horgan S; Bemelman WA; Dunst CM; Edmundowicz SA; Lipham JC; Luketich JD; Melvin WS; Oelschlager BK; Schlack-Haerer SC; Smith CD; Smith CC; Dunn D; Taiganides PA
    N Engl J Med; 2013 Feb; 368(8):719-27. PubMed ID: 23425164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the outcome of magnetic sphincter augmentation for chronic gastroesophageal reflux disease.
    Warren HF; Brown LM; Mihura M; Farivar AS; Aye RW; Louie BE
    Surg Endosc; 2018 Jan; 32(1):405-412. PubMed ID: 28664433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.